中国医药导报
中国医药期刊欢迎您 今天是   2025年4月6日星期天
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  论著 本期目录 | 过刊浏览 | 高级检索 |
滋阴通络方对去卵巢骨质疏松大鼠骨代谢及骨密度的影响
孙凯1      陈荣彬2      杨英东1      李勇2
1.广州中医药大学第二临床医学院,广东广州   510405;
2.广东省中医院珠海医院骨三科,广东珠海   519000
Effect of Ziyin Tongluo Decoction on bone metabolism and bone mineral density in ovariectomized osteoporosis rats#br#
SUN Kai1   CHEN Rongbin2   YANG Yingdong1   LI Yong2
1.The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangdong Province, Guangzhou   510405, China; 
2.the Third Branch of Department of Orthopedics, Zhuhai Hospital, Traditional Chinese Medical Hospital of Guangdong Province, Guangdong Province, Zhuhai   519000, China
全文: PDF (1186 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨滋阴通络方对去卵巢骨质疏松大鼠骨代谢及骨密度的影响。 方法 取50只SD雌性大鼠建立去卵巢大鼠模型,另取10只SD大鼠设置为假手术组。将建模成功的大鼠按照随机数字表法分为模型组,西药组[阿仑膦酸钠(10.51 mg/kg)与阿法骨化醇(0.075 μg/kg)],滋阴通络方低(1.34 g/kg)、中(2.68 g/kg)、高(4.02 g/kg)剂量组,每组10只,对其进行灌胃治疗。治疗12周后,测定各组大鼠骨密度(BMD)、骨微结构及血清中Ⅰ前胶原氨基端原肽(PⅠNP)、Ⅰ型胶原氨基末端肽(NTX)和Ⅰ型胶原C末端肽(CTX-Ⅰ)含量。 结果 与假手术组比较,模型组BMD、骨体积分数、骨小梁数量、骨小梁厚度及PⅠNP水平降低,差异有统计学意义(P < 0.05);骨小梁分离度、骨小梁模式因子、结构模型指数、NTX及CTX-Ⅰ水平升高,差异有统计学意义(P < 0.05);与模型组比较,滋阴通络方各剂量组BMD、骨体积分数、骨小梁数量、骨小梁厚度及PⅠNP水平升高;骨小梁分离度、骨小梁模式因子、结构模型指数、NTX和CTX-Ⅰ水平降低,差异有统计学意义(P < 0.05)。滋阴通络方不同剂量组组间比较,差异无统计学意义(P > 0.05)。 结论 滋阴通络方可改善去卵巢大鼠骨代谢、提高骨密度,改善骨显微结构,达到治疗绝经后骨质疏松症的作用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
孙凯1 陈荣彬2 杨英东1 李勇2
关键词 滋阴通络方去卵巢大鼠绝经后骨质疏松症骨代谢骨密度    
Abstract:Objective To investigate the effect of Ziyin Tongluo Decoction on bone metabolism and bone mineral density in ovariectomized osteoporosis rats. Methods Fifty SD female rats were selected to establish ovariectomized rat model, and another ten SD rats were selected as the sham operation group. The rats were divided into model group, Western medicine group (Alendronate Sodium [10.51 mg/kg] and Alfacalccitalol [0.075 μg/kg]), Ziyin Tongluo Decoction low-dose (1.34 g/kg), medium-dose (2.68 g/kg) and high-dose (4.02 g/kg) groups according to random number table method, with ten rats in each group. They were treated by gavage. After 12 weeks of treatment, bone mineral density(BMD), bone microstructure and serum contents of procollagen Ⅰ N-terminal propeptide (PⅠNP), N-terminal telopeptide of type Ⅰ collagen(NTX), and C-telopeptide of type Ⅰ collagen (CTX-Ⅰ) were determined. Results Compared with sham operation group, BMD, bone volume fraction, bone trabecular number, bone trabecular thickness, and PⅠNP level were decreased in model group, and the differences were statistically significant (P < 0.05). The trabecular separation, trabecular pattern factor, structural model index, NTX, and CTX-Ⅰ levels were increased in model group, and the differences were statistically significant (P < 0.05). Compared with model group, BMD, bone volume fraction, bone trabecular number, bone trabecular thickness and PⅠNP level in Ziyin Tongluo Decoction groups were increased; the trabecular separation, trabecular pattern factor, structural model index, NTX, and CTX-Ⅰ levels were decreased, and the differences were statistically significant (P < 0.05). There was no significant difference between groups with different doses of Ziyin Tongluo Decoction (P > 0.05). Conclusion Ziyin Tongluo Decoction can improve bone metabolism, increase bone density and improve bone microstructure of ovariectomized rats, and achieve the effect of postmenopausal osteoporosis treatment.
Key wordsZiyin Tongluo Decoction    Ovariectomied rats    Postmenopausal osteoporosis    Bone metabolism    Bone mineral density
    
基金资助:广东省中医药管理局基金项目(20194010)。
通讯作者: 李勇(1967-),男,硕士,教授,广东省中医院珠海医院骨三科主任;研究方向:中西医结合治疗脊柱疾病。   
作者简介: 孙凯(1994-),男,硕士;研究方向:中西医结合治疗脊柱疾病。
引用本文:   
孙凯1 陈荣彬2 杨英东1 李勇2. 滋阴通络方对去卵巢骨质疏松大鼠骨代谢及骨密度的影响[J]. 中国医药导报, 2021, 18(34): 26-29,38.
SUN Kai1 CHEN Rongbin2 YANG Yingdong1 LI Yong2. Effect of Ziyin Tongluo Decoction on bone metabolism and bone mineral density in ovariectomized osteoporosis rats#br#. 中国医药导报, 2021, 18(34): 26-29,38.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/     或     https://www.yiyaodaobao.com.cn/CN/Y2021/V18/I34/26

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司